FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer

S Zaghdoudi, E Decaup, I Belhabib… - EMBO molecular …, 2020 - embopress.org
Cancer‐associated fibroblasts (CAF s) are considered the most abundant type of stromal
cells in pancreatic ductal adenocarcinoma (PDAC), playing a critical role in tumour …

[HTML][HTML] The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma

A Begum, T Ewachiw, C Jung, A Huang, KJ Norberg… - PloS one, 2017 - journals.plos.org
Cancer stem cells (CSCs) play an important role in the clonogenic growth and metastasis of
pancreatic ductal adenocarcinoma (PDAC). A hallmark of PDAC is the desmoplastic …

Direct interactions with cancer-associated fibroblasts lead to enhanced pancreatic cancer stem cell function

A Begum, RH McMillan, YT Chang, VR Penchev… - Pancreas, 2019 - journals.lww.com
Objective Cancer-associated fibroblasts (CAFs) play an important role in the progression of
pancreatic ductal adenocarcinoma (PDAC) by promoting tumor cell migration and drug …

FAK is involved in invasion and metastasis of hepatocellular carcinoma

JS Chen, XH Huang, Q Wang, XL Chen, XH Fu… - Clinical & experimental …, 2010 - Springer
Studies have shown that focal adhesion kinase (FAK) is overexpressed in several human
tumors and plays an important role in tumor progression. However, the role and underlying …

Suppression of endothelial cell FAK expression reduces pancreatic ductal adenocarcinoma metastasis after gemcitabine treatment

M Roy-Luzarraga, LE Reynolds, B de Luxán-Delgado… - Cancer Research, 2022 - AACR
Despite substantial advances in the treatment of solid cancers, resistance to therapy
remains a major obstacle to prolonged progression-free survival. Pancreatic ductal …

FAK signaling in human cancer as a target for therapeutics

BY Lee, P Timpson, LG Horvath, RJ Daly - Pharmacology & therapeutics, 2015 - Elsevier
Focal adhesion kinase (FAK) is a key regulator of growth factor receptor-and integrin-
mediated signals, governing fundamental processes in normal and cancer cells through its …

Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion

H Jiang, X Liu, BL Knolhoff, S Hegde, KB Lee, H Jiang… - Gut, 2020 - gut.bmj.com
Objective We investigated how pancreatic cancer developed resistance to focal adhesion
kinase (FAK) inhibition over time. Design Pancreatic ductal adenocarcinoma (PDAC) …

[HTML][HTML] Targeting FAK in human cancer: from finding to first clinical trials

VM Golubovskaya - Frontiers in bioscience (Landmark edition), 2014 - ncbi.nlm.nih.gov
It is twenty years since Focal Adhesion Kinase (FAK) was found to be overexpressed in
many types of human cancer. FAK plays an important role in adhesion, spreading, motility …

FAK in cancer: mechanistic findings and clinical applications

FJ Sulzmaier, C Jean, DD Schlaepfer - Nature reviews cancer, 2014 - nature.com
Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed
and activated in several advanced-stage solid cancers. FAK promotes tumour progression …

[HTML][HTML] FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer

C Davidson, D Taggart, AH Sims, DW Lonergan… - British Journal of …, 2022 - nature.com
Abstract Background Pancreatic Cancer is one of the most lethal cancers, with less than 8%
of patients surviving 5 years following diagnosis. The last 40 years have seen only small …